Skip to main content

Articles

Page 42 of 76

  1. Despite a good and overall prognosis, papillary thyroid cancer (PTC) can still affect the quality of life of many patients, and can even be life-threatening due to its invasiveness and metastasis. Emerging stu...

    Authors: Yao Yao, Xinyuan Chen, Hong Yang, Wei Chen, Yichun Qian, Zhongyi Yan, Tian Liao, Weiping Yao, Wenlan Wu, Tonghua Yu, Yun Chen and Yuan Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:318
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2020 39:56

  2. Acquired resistance remains a limitation of the clinical use of 5-fluorouracil (5-FU). Because exosomes, are important vesicles participating in intercellular communication, their contribution to the developme...

    Authors: Qian Zhang, Rui-Xian Liu, Ka-Wo Chan, Jiancong Hu, Jingdan Zhang, Lili Wei, Huiliu Tan, Xiangling Yang and Huanliang Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:320
    Content type: Research Published on:

  3. Recurrence and metastasis are the leading causes of tumour-related death in patients with oesophageal squamous cell carcinoma (ESCC). Tumour-infiltrating natural killer cells (NK cells) display powerful cytoto...

    Authors: Jian Wu, Feng-xia Gao, Chao Wang, Mei Qin, Fei Han, Tao Xu, Zhi Hu, Yang Long, Xue-mei He, Xin Deng, De-lian Ren and Tian-yang Dai
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:321
    Content type: Research Published on:

  4. CDK4/6 inhibitors are a promising treatment strategy in tumor therapy but are hampered by resistance mechanisms. This study was performed to reveal predictive markers, mechanisms of resistance and to develop r...

    Authors: Zhichao Tong, Anuja Sathe, Benedikt Ebner, Pan Qi, Christian Veltkamp, Juergen E. Gschwend, Per Sonne Holm and Roman Nawroth
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:322
    Content type: Research Published on:

  5. Numerous studies have presented that curcumin could have a positive effect in the prevention of cancer and then in tumor therapy. Several hypotheses have highlighted that curcumin could decreases tumor growth ...

    Authors: Alexandre Vallée, Yves Lecarpentier and Jean-Noël Vallée
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:323
    Content type: Review Published on:

  6. The human ether a-go-go-related gene 1 (HERG1) is involved in tumor progression; however, its role in esophageal squamous cell carcinoma (ESCC) is not well studied. This study investigated HERG1 function in ES...

    Authors: Hongqiang Wang, Xuchun Yang, Yan Guo, Lin Shui, Shi Li, Yifeng Bai, Yu Liu, Ming Zeng and Jianling Xia
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:324
    Content type: Research Published on:

  7. Sodium/iodide symporter (NIS)-mediated iodide uptake plays an important physiological role in regulating thyroid gland function, as well as in diagnosing and treating Graves’ disease and thyroid cancer. High-m...

    Authors: Wenwen Chai, Fanghua Ye, Li Zeng, Yanling Li and Liangchun Yang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:325
    Content type: Research Published on:

  8. Prostate cancer (PCa) is the second leading cause of cancer-related death in the Western population. The use in oncology of positron emission tomography/computed tomography (PET/CT) with emerging radiopharmace...

    Authors: B. Frigerio, S. Morlino, E. Luison, E. Seregni, A. Lorenzoni, A. Satta, R. Valdagni, A. Bogni, C. Chiesa, M. Mira, S. Canevari, A. Alessi and M. Figini
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:326
    Content type: Research Published on:

  9. Malignant tumors are often multifactorial. Epidemiological studies have shown that hyperglycemia raises the prevalence and mortality of certain malignancies, like breast, liver, bladder, pancreatic, colorectal...

    Authors: Wenjie Li, Xuehui Zhang, Hui Sang, Ying Zhou, Chunyu Shang, Yongqing Wang and Hong Zhu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:327
    Content type: Review Published on:

  10. Tumor heterogeneity results in differential response to therapy due to the existence of plastic tumor cells, called cancer stem cells (CSCs), which exhibit the property of resistance to therapy, invasion and m...

    Authors: Pavana Thomas, Annapurna Pranatharthi, Cecil Ross and Sweta Srivastava
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:328
    Content type: Review Published on:

  11. Kinesins play important roles in the development and progression of many human cancers. The functions and underlying mechanisms of kinesin family member C1 (KIFC1), a member of the kinesin-14 family, in the pa...

    Authors: Kai Teng, Shi Wei, Chi Zhang, Jiewei Chen, Jinbin Chen, Kanghua Xiao, Jun Liu, Miaomiao Dai, Xinyuan Guan, Jingping Yun and Dan Xie
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:329
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2021 40:135

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2019 38:442

  12. RelA/p65 a crucial member of NF-κB signaling pathway plays diverse role in mediating oncogenesis. Limited knowledge prevails on the mechanistic insights of RelA gene regulation. RNA helicase p68 apart from bei...

    Authors: Veenita Khare, Shaheda Tabassum, Uttara Chatterjee, Sandip Chatterjee and Mrinal K. Ghosh
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:330
    Content type: Research Published on:

  13. In the original publication of this article [1], the Gene Expression Omnibus (GEO) accession code GSE79772 is wrong. The correct accession code should be GSE86213.

    Authors: Yinfang Wang, Yanli Hou, Weiwei Zhang, Angel A. Alvarez, Yongrui Bai, Bo Hu, Shi-Yuan Cheng, Kun Yang, Yanxin Li and Haizhong Feng
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:331
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:147

  14. Immunotherapeutic approaches designed to augment T and B cell mediated killing of tumor cells has met with clinical success in recent years suggesting tremendous potential for treatment in a broad spectrum of ...

    Authors: Lawrence H. Cheung, Yunli Zhao, Ana Alvarez-Cienfuegos, Khalid A. Mohamedali, Yu J. Cao, Walter N. Hittelman and Michael G. Rosenblum
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:332
    Content type: Research Published on:

  15. Cathepsin L (CTSL) is a cysteine protease known to have important roles in regulating cancer cellular resistance to chemotherapy. However mechanism underlying which regulates CTSL-mediated drug resistance rema...

    Authors: Yifan Zhao, Xiao Shen, Ying Zhu, Anqi Wang, Yajie Xiong, Long Wang, Yao Fei, Yan Wang, Wenjuan Wang, Fang Lin and Zhongqin Liang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:333
    Content type: Research Published on:

  16. Runt-related transcription factor 1 (RUNX1) plays the roles of an oncogene and an anti-oncogene in epithelial tumours, and abnormally elevated RUNX1 has been suggested to contribute to the carcinogenesis of co...

    Authors: Qingyuan Li, Qiuhua Lai, Chengcheng He, Yuxin Fang, Qun Yan, Yue Zhang, Xinke Wang, Chuncai Gu, Yiqing Wang, Liangying Ye, Lu Han, Xin Lin, Junsheng Chen, Jianqun Cai, Aimin Li and Side Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:334
    Content type: Research Published on:

  17. The chemical carcinogen 3-methylcholanthrene (3MC) binds to the aryl hydrocarbon receptor (AHR) that regulates the expression of cytochrome P450 (CYP) enzymes as CYP1B1, which is involved in the oncogenic acti...

    Authors: Francesca Cirillo, Rosamaria Lappano, Leonardo Bruno, Bruno Rizzuti, Fedora Grande, Rita Guzzi, Sara Briguori, Anna Maria Miglietta, Miki Nakajima, Maria Teresa Di Martino and Marcello Maggiolini
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:335
    Content type: Research Published on:

  18. In the original publication of this article [1], the authors reported the order of the authors was incorrect and needs to be revised. The original article has been updated to rectify this error.

    Authors: Qing Yang, Binhui Xie, Hui Tang, Wei Meng, Changchang Jia, Xiaomei Zhang, Yi Zhang, Jianwen Zhang, Heping Li and Binsheng Fu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:336
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:263

  19. Pancreatic Ductal Adenocarcinoma (PDAC) is an aggressive and lethal disease, lacking effective therapeutic approaches. Available therapies only marginally prolong patient survival and are frequently coupled wi...

    Authors: Aleksandra Adamska, Alice Domenichini, Emily Capone, Verena Damiani, Begum Gokcen Akkaya, Kenneth J. Linton, Pierluigi Di Sebastiano, Xi Chen, Adam B. Keeton, Veronica Ramirez-Alcantara, Yulia Maxuitenko, Gary A. Piazza, Vincenzo De Laurenzi, Gianluca Sala and Marco Falasca
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:312
    Content type: Research Published on:

  20. Metabolic rewiring is a common feature of many cancer types, including prostate cancer (PCa). Alterations in master genes lead to mitochondrial metabolic rewiring and provide an appealing target to inhibit can...

    Authors: Jiaxin Fan, Yanru Fan, Xiao Wang, Lingfang Niu, Limei Duan, Jinxiao Yang, Luo Li, Yingying Gao, Xiaohou Wu and Chunli Luo
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:337
    Content type: Research Published on:

  21. The GKN2 is a secretory protein, whose levels decrease in gastric cancer. The present study aimed to investigate the expression, function and mechanism of action of GKN2 in gastric cancer.

    Authors: Ziqiang Zhang, Hongyuan Xue, Yuanqiang Dong, Jun Zhang, Yida Pan, Liubin Shi, Panpan Xiong, Jie Zhu, Wenshuai Li, Wanwei Zheng, Jie Liu and Jianjun Du
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:338
    Content type: Research Published on:

  22. Glioma initiating cells (GICs), also known as glioma stem cells (GSCs), play an important role in the progression and recurrence of glioblastoma multiforme (GBM) due to their potential for self-renewal, multip...

    Authors: Li Yi, Xingchen Zhou, Tao Li, Peidong Liu, Long Hai, Luqing Tong, Haiwen Ma, Zhennan Tao, Yang Xie, Chen Zhang, Shengping Yu and Xuejun Yang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:339
    Content type: Research Published on:

  23. Pancreatic ductal adenocarcinoma is one of the most aggressive cancers, with a 5-year survival rate of less than 8%. The complicated tumor microenvironment, particularly TGF-β, provides possible convenience fo...

    Authors: Ruizhi He, Min Wang, Chunle Zhao, Ming Shen, Yahong Yu, Li He, Yan Zhao, Hua Chen, Xiuhui Shi, Min Zhou, Shutao Pan, Yuhui Liu, Xingjun Guo, Xu Li and Renyi Qin
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:340
    Content type: Research Published on:

  24. Prostate tumor over expressed gene 1 (PTOV1) has been reported as an oncogene in several human cancers. However, the clinical significance and biological role of PTOV1 remain elusive in non-small cell lung can...

    Authors: Zhiqiang Wu, Zhuang Liu, Xiangli Jiang, Zeyun Mi, Maobin Meng, Hui Wang, Jinlin Zhao, Boyu Zheng and Zhiyong Yuan
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:341
    Content type: Research Published on:

  25. Androgen receptor (AR)-targeted treatments improve the survival of castration-resistant prostate cancer (CRPC) patients; however, secondary resistance to these agents ultimately occurs in virtually all patient...

    Authors: Sahyun Pak, Sejun Park, Yunlim Kim, Jung-Hyuck Park, Chan-Hee Park, Kyoung-June Lee, Choung-soo Kim and Hanjong Ahn
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:342
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2019 38:440

  26. Kidney Renal Clear Cell Carcinoma (KIRC) accounts for 75% of all renal cancers. Previous study had conflict evidences regarding NR1B2 role in cancer, and its expression and biological role in KIRC remained unc...

    Authors: Lei Yin, Wenjia Li, Guangchun Wang, Heng Shi, Keyi Wang, Huan Yang and Bo Peng
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:343
    Content type: Research Published on:

  27. Accumulated evidences have demonstrated that long non-coding RNAs (lncRNAs) are dysregulated and correlate with the pathophysiological basis of malignant tumors. The objective of this research is to uncover th...

    Authors: Chen Qi, Chen Xiaofeng, Li Dongen, Yang Liang, Xu Liping, Hu Yue and Jiang Jianshuai
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:344
    Content type: Research Published on:

  28. Epithelial ovarian cancer (EOC) is the malignant tumor of the female reproductive system with the highest fatality rate. Tolerance of chemotherapeutic drugs like cisplatin (DDP) occurring in very early stage i...

    Authors: Xiaoran Long, Keqi Song, Hao Hu, Qi Tian, Wenjing Wang, Qian Dong, Xia Yin and Wen Di
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:345
    Content type: Research Published on:

  29. RUNX2 is a Runt-related transcription factor required during embryogenesis for skeletal development and morphogenesis of other organs including thyroid and breast gland. Consistent evidence indicates that RUNX...

    Authors: Gloria Manzotti, Federica Torricelli, Benedetta Donati, Valentina Sancisi, Mila Gugnoni and Alessia Ciarrocchi
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:346
    Content type: Research Published on:

  30. Pancreatic cancer is a highly lethal malignancy with poor prognosis. Anillin (ANLN), an actin binding protein, is upregulated and plays an important role in many malignant tumors. However, the precise role of ...

    Authors: Anbin Wang, Haisu Dai, Yi Gong, Chengcheng Zhang, Junjie Shu, Yuandeng Luo, Yan Jiang, Wei Liu and Ping Bie
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:347
    Content type: Research Published on:

  31. Ten-eleven translocation 1 (TET1) is a dioxygenase that converts 5-methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC) to induce DNA demethylation. TET1 has been reported to be absent in cancers, and to i...

    Authors: Jian Wu, Hongzhe Li, Minmin Shi, Youwei Zhu, Yang Ma, Yiming Zhong, Cheng Xiong, Hao Chen and Chenghong Peng
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:348
    Content type: Research Published on:

  32. Over the past decade, newly designed cancer therapies have not significantly improved the survival of patients diagnosed with Malignant Pleural Mesothelioma (MPM). Among a limited number of genes that are freq...

    Authors: Claudio Pulito, Etleva Korita, Andrea Sacconi, Mariacristina Valerio, Luca Casadei, Federica Lo Sardo, Federica Mori, Maria Ferraiuolo, Giuseppe Grasso, Anna Maidecchi, Jacopo Lucci, Marius Sudol, Paola Muti, Giovanni Blandino and Sabrina Strano
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:349
    Content type: Research Published on:

  33. Ubiquitin E3 ligase CUL4A plays important oncogenic roles in the development of cancers. DTL, one of the CUL4-DDB1 associated factors (DCAFs), may involve in the process of cancer development. Programmed cell ...

    Authors: Haoran Cui, Qin Wang, Zhenchuan Lei, Maoxiao Feng, Zhongxi Zhao, Yunshan Wang and Guangwei Wei
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:350
    Content type: Research Published on:

  34. Soluble fibrinogen-like protein 2 (sFGL2), a secretory protein expressed by regulatory T cells (Tregs) with immunosuppressive activity, is highly expressed in both the peripheral blood and tumor tissue of pati...

    Authors: Muyang Yang, Zhongwei Zhang, Jiajia Chen, Mengying Xu, Jiaquan Huang, Ming Wang, Weina Li, Xiaoyang Wan, Man-Fung Yuen, Xiaoping Luo, Dong Xi and Qin Ning
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:351
    Content type: Research Published on:

  35. In the original publication of this article [1], the author’ affiliations need to be revised, because the first and second affiliations should combine as the same affiliation.

    Authors: Haoming Mai, Bin Zhou, Li Liu, Fu Yang, Carly Conran, Yuan Ji, Jinlin Hou and Deke Jiang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:352
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:198

  36. Tubeimoside-I (TBM), a plant-derived bioactive compound, shows antitumor activity in different tumors and can enhance the efficacy of chemotherapeutic agents. However, the detail mechanism underlying remains t...

    Authors: Jianghong Yan, Xiaoyun Dou, Jing Zhou, Yuanfeng Xiong, Ling Mo, Longhao Li and Yunlong Lei
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:353
    Content type: Research Published on:

  37. Estrogen receptor β (ERβ) has been reported to play an anti-cancer role in breast cancer, but the regulatory mechanism by which ERβ exerts this effect is not clear. Claudin-6 (CLDN6), a tight junction protein,...

    Authors: Peiye Song, Yanru Li, Yuan Dong, Yingying Liang, Huinan Qu, Da Qi, Yan Lu, Xiangshu Jin, Yantong Guo, Yiyang Jia, Xinqi Wang, Wenhong Xu and Chengshi Quan
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:354
    Content type: Research Published on:

  38. Human epidermal growth factor receptor 2 (HER2) is overexpressed in multiple cancers, which is associated with poor prognosis. Herceptin and other agents targeting HER2 have potent antitumor efficacy in patien...

    Authors: Shengnan Yu, Jing Zhang, Yongxiang Yan, Xudong Yao, Lijuan Fang, Hui Xiong, Yang Liu, Qian Chu, Pengfei Zhou and Kongming Wu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:355
    Content type: Research Published on:

  39. Long noncoding RNAs (lncRNAs) have been reported to be associated with the proliferation of several cancer cells. The aim of this study was to investigate the role of FLVCR1-AS1 in ovarian serous cancer (OSC).

    Authors: Huan Yan, Hong Li, Maria A. Silva, Yichun Guan, Li Yang, Linlin Zhu, Zhan Zhang, Genxia Li and Chenchen Ren
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:356
    Content type: Research Published on:

  40. In the original publication of this article [1], there is a mistake in Fig. 4E.

    Authors: Qianqian Liu, Hongye Ma, Xiuhua Sun, Bing Liu, Yang Xiao, Shimeng Pan, Huimin Zhou, Weijie Dong and Li Jia
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:357
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:199

  41. MicroRNAs (miRNAs) play crucial roles in tumor initiation and development. Previously, we indicated that miR-504 is downregulated and suppresses tumor proliferation in glioblastoma (GBM). However, the regulati...

    Authors: Qiang Liu, Yanlei Guan, Zhenhang Li, Yao Wang, Yu Liu, Run Cui and Yunjie Wang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:358
    Content type: Research Published on:

  42. Epidemiological observations have demonstrated that ambient fine particulate matter with dp < 2.5 μm (PM2.5) as the major factor responsible for the increasing incidence of lung cancer in never-smokers. However, ...

    Authors: Ming-Yue Li, Li-Zhong Liu, Wende Li, Calvin S. H. Ng, Yi Liu, Angel W. Y. Kong, Zhili Zhao, Shanshan Wang, Haolong Qi, Hao Jia, Shucai Yang, Jing Du, Xiang Long, Rocky L. K. Ho, Ernest C. W. Chak, Innes Y. P. Wan…
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:359
    Content type: Research Published on:

  43. A major limitation in the treatment for malignant mesothelioma is related to serious side effects caused by chemotherapeutics and to the development of cancer-resistance. Advances in cancer therapies have been...

    Authors: Francesco Di Meo, Stefania Filosa, Michele Madonna, Gerarda Giello, Alba Di Pardo, Vittorio Maglione, Alfonso Baldi and Stefania Crispi
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:360
    Content type: Research Published on:

  44. Triple Negative Breast cancer (TNBC) is incurable cancer with higher rates of relapse and shorter overall survival compared with other subtypes of breast cancer. Cellular retinoic acid binding protein 2 (CRABP...

    Authors: Xuefei Feng, Miao Zhang, Bo Wang, Can Zhou, Yudong Mu, Juan Li, Xiaoxu Liu, Yaochun Wang, Zhangjun Song and Peijun Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:361
    Content type: Research Published on:

  45. Tumor targeting small molecular inhibitors are the most popular treatments for many malignant diseases, including cancer. However, the lower clinical response and drug resistance still limit their clinical eff...

    Authors: Xiaoge Gao, Pin Jiang, Qian Zhang, Qian Liu, Shuangshuang Jiang, Ling Liu, Maomao Guo, Qian Cheng, Junnian Zheng and Hong Yao
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:362
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2023 42:87

  46. In order to develop a new immunotherapeutic agent targeting metastatic breast cancers, we chose to utilize autocatalytic feature of the membrane serine protease Prss14/ST14, a specific prognosis marker for ER ...

    Authors: Ki Yeon Kim, Minsang Yoon, Youngkyung Cho, Kwang-Hoon Lee, Sora Park, Se-ra Lee, So-Young Choi, Deokjae Lee, Chansik Yang, Eun Hye Cho, Sangjun Davie Jeon, Seok-Hyung Kim, Chungho Kim and Moon Gyo Kim
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:363
    Content type: Research Published on:

  47. Microsatellite unstable colorectal cancers (MSI+ CRCs) expressing PD-L1, respond to anti-PD-1 or anti-PD-L1 checkpoint blockade, whereas microsatellite-stable tumors do not respond the same. Our aim was to exa...

    Authors: Apostolos Zaravinos, Constantinos Roufas, Majdi Nagara, Beatriz de Lucas Moreno, Maria Oblovatskaya, Christodoulos Efstathiades, Christos Dimopoulos and Georgios D. Ayiomamitis
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:364
    Content type: Research Published on:

  48. The lncRNA LINC00460 plays crucial roles in several epithelial cancers, although its mechanisms of action differ greatly in different cellular contexts. In this study, we aimed to determine the potential clini...

    Authors: Yingying Jiang, Wei Cao, Kun Wu, Xing Qin, Xiaoning Wang, Yan Li, Binbin Yu, Zhen Zhang, Xu Wang, Ming Yan, Qin Xu, Jianjun Zhang and Wantao Chen
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:365
    Content type: Research Published on:

  49. The epithelial-to-mesenchymal transition (EMT) has been linked to the regulation of glioma progression. However, the underlying signaling mechanisms that regulate EMT are poorly understood.

    Authors: Erbao Bian, Xueran Chen, Yadi Xu, Xinghu Ji, Meng Cheng, Hongliang Wang, Zhiyou Fang and Bing Zhao
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:366
    Content type: Research Published on:

  50. In the publication of this article [1], there is an error in Fig. 5C (panel 4, group of InmiR-26a + silinc01296 in SW620). The revised Fig. 5 which includes 5C has now been included in this correction.

    Authors: Bing Liu, Shimeng Pan, Yang Xiao, Qianqian Liu, Jingchao Xu and Li Jia
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:367
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:316

Annual Journal Metrics

  • 2022 Citation Impact
    11.3 - 2-year Impact Factor
    11.5 - 5-year Impact Factor
    1.870 - SNIP (Source Normalized Impact per Paper)
    2.413 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    100 days submission to accept (Median)

    2023 Usage 
    3,003,080 downloads
    3,022 Altmetric mentions

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us